(Total Views: 351)
Posted On: 01/11/2020 9:48:19 AM
Post# of 154852
Noted in 10Q verbage "The change in circulating
tumor cells ("CTCs"
number will be evaluated every 21 days during treatment and
will be used as an initial prognostic marker for efficacy. Up to 48 patients are
expected to be enrolled in this study."
This is for the TNBC trial, so it seems we should not expect CTC updates for at least 21 days per patient at best.
tumor cells ("CTCs"
number will be evaluated every 21 days during treatment and will be used as an initial prognostic marker for efficacy. Up to 48 patients are
expected to be enrolled in this study."
This is for the TNBC trial, so it seems we should not expect CTC updates for at least 21 days per patient at best.
(0)
(0)
